FDA Panel Scheduled to Review Second Sight’s Argus® II Retinal Prosthesis System
05:00 EDT 20 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Second
Sight Medical Products Inc., the world’s leading developer and
manufacturer of retinal prostheses, today announced that a U.S. Food and
Drug Administration (FDA) Ophthalmic Devices Advisory Panel has been
schedul...
Other Sources for this Article
Second Sight Medical Products Inc.
Brian Mech, 1-818-833-5026
bmech@2-sight.com
More From BioPortfolio on "FDA Panel Scheduled to Review Second Sight’s Argus® II Retinal Prosthesis System"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
